However, in the severe COVID-19 patients, the titer of anti-MDA5 Ab boosts up in the 1st week after symptom onset and subsequently remains at a high positivity although a decreased titer is observed at weeks 2, 3, and 4 (Figure 4M). This evidence concerns the gene IFIH1 and COVID-19.